Table 1

Baseline characteristics of patients and healthy control subjects


Patients
Controls




Fibromyalgia
Chronic fatigue syndrome





Variable
(N = 68)
(N = 62)
(N = 46)

Age (years)
31.43 ± 7.81
32.55 ± 6.61
31.54 ± 6.86
Disease duration (years)
3.96 ± 4.23
4.28 ± 4.12
-
FIQ score
59.23 ± 10.28
-
12.83 ± 7.21
Pain intensity (VAS)
5.03 ± 1.18
4.49 ± 1.83
0.47 ± 0.880
Tender point count
13.18 ± 1.79
6.49 ± 3.51
3.49 ± 2.81
Symptoms experienced [No. (%)]



     Morning stiffness
42 (62)
24 (39)
3 (7)
     Muscle spasm
39 (57)
15 (24)
2 (4)
     Fatigue
48 (71)
62 (100)
4 (9)
     Skinfold tenderness
56 (82)
29 (47)
2 (4)
     Sleep disturbance
54 (79)
27 (44)
2 (4)
     Cigarette smoking
31 (46)
30 (48)
26 (57)
Menstrual cycle



     Age at menarche
12.91 ± 0.28
13.02 ± 0.25
13.14 ± 0.21
     Cycle length (days)
13.14 ± 0.21
28.87 ± 0.19
29.07 ± 0.27
     Days of menstrual flow
4.82 ± 0.36
4.97 ± 0.28
4.89 ± 0.32
Marital status [No. (%)]



     Married
45 (66)
39 (63)
28 (61)
     Single
13 (20)
14 (23
10 (23)
     Divorced
7 (12)
6 (10)
4 (9)
     Other
3 (2)
3 (4)
3 (7)
Highest educational level achieved [No. (%)]



     Elementary school
31 (46)
30 (48)
20 (44)
     Secondary school
15 (22)
13 (21)
13 (28)
     University/High school
22 (32)
19 (31)
13 (28)
Employment status [No. (%)]



     Unemployed
5 (7)
5 (8)
3 (7)
     Employed
7 (10)
5 (8)
7 (15)
     Retired
3 (4)
4 (6)
2 (4)
     Homemaker
39 (58)
37 (60)
24 (52)
     Student
11 (16)
8 (13)
7 (15)
     Others
3 (5)
3 (5)
3 (7)

Values are means ± standard deviation, except where indicated as number and percentage of the group. FIQ, Fibromyalgia Impact Questionnaire; VAS: Visual Analog Scale; -, not applicable.

Gur et al. Arthritis Res Ther 2004 6:R232   doi:10.1186/ar1163

Open Data